Animal models of peripheral neuropathy due to environmental toxicants

ILAR Journal

Volumn 54, Issue 3, 2014, Pages 315-323

  Rao, Deepa B ^a   Jortner, Bernard S ^b   Sills, Robert C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

Acrylamide; Carbon disulfide; Environmental toxicant; Hexacarbon; Organophosphate; Peripheral neuropathy; Pyridoxine; Vitamin B6

Indexed keywords

ACRYLAMIDE; CARBON DISULFIDE; DANGEROUS GOODS; HEXANE; ORGANOPHOSPHATE; PYRIDOXINE;

ANIMAL; CHEMICALLY INDUCED; DANGEROUS GOODS; DISEASE MODEL; HISTOLOGY; PATHOLOGY; PERIPHERAL NEUROPATHY; TOXICITY;

ACRYLAMIDE; ANIMALS; CARBON DISULFIDE; DISEASE MODELS, ANIMAL; HAZARDOUS SUBSTANCES; HEXANES; HISTOLOGICAL TECHNIQUES; ORGANOPHOSPHATES; PERIPHERAL NERVOUS SYSTEM DISEASES; PYRIDOXINE;

EID: 84897874119     PISSN: 10842020     EISSN: 19306180     Source Type: Journal    
DOI: 10.1093/ilar/ilt058     Document Type: Article

References (89)

1. Abou-Donia MB. 1995. Organophosphorus Pesticides. In: Chang W, Dyer RS, eds. Handbook of Neurotoxicology. Marcel Dekker, Inc., New York: Marcel Dekker. p: 419-473.
2. Allen N, Mendell JR, Billmaier DJ, Fontaine RE, O'neill J. 1975. Toxic polyneuropathy due to methyl n-butyl ketone. An industrial outbreak. Arch Neurol 32:209-218.
3. Altenkirch H, Mager J, Stoltenburg G, Helmbrecht J. 1977. Toxic polyneuropathies after sniffing a glue thinner. J Neurol 214:137-152.
4. Altenkirch H, Stoltenburg-Didinger G, Koeppel C. 1988. The neurotoxicological aspects of the toxic oil syndrome (TOS) in Spain. Toxicology 49:25-34.
5. Aring CD. 1942. The systemic nervous affinity of troorthocresyl phosphate (Jamaican ginger palsy). Brain 65:34-47.
6. Auld RB, Bedwell SF. 1967. Peripheral neuropathy with sympathetic overactivity from industrial contact with acrylamide. Canad Med Ass J 96:652-654.
7. Bakir F, Damluji SF, Amin-Zaki L, Murtadha M, Khalidi A, al-Rawi NY, Tikriti S, Dahahir HI, Clarkson TW, Smith JC, Doherty RA. 1973. Methylmercury poisoning in Iraq. Science 181:230-241.
8. Bolon B, Garman RH, Pardo ID, Jensen K, Sills RC, Roulois A, Radovsky A, Bradley A, Andrew-Jones L, Butt M, Gumprecht L. 2013. STP position paper: recommended practices for sampling and processing the nervous system (brain, spinal cord, nerve, and eye) during non-clinical general toxicity studies. Toxicol Pathol. 41:1028-1048.
9. Cavanagh JB. 1954. The toxic effects of triortho-cresyl phosphate on the nervous system; an experimental study in hens. J Neurol Neurosurg Psychiatry 17:163-172.
10. Cavanagh JB. 1964. The significance of the "dying back" process in experimental and human neurological disease. Int Rev Exp Pathol 3:219-267.
11. Cavanagh JB, Fuller NH, Johnson HR, Rudge P. 1974. The effects of thallium salts, with particular reference to the nervous system changes. A report of three cases. Q J Med 43:293-319.
12. Cavanagh JB, Nolan CC. 1982. Selective loss of Purkinje cells from the rat cerebellum caused by acrylamide and the responses of betaglucuronidase and beta-galactosidase. Acta Neuropathol. 58:210-214.
13. Chong PH, Boskovich A, Stevkovic N, Bartt RE. 2004. Statin-associated peripheral neuropathy: Review of the literature. Pharmacotherapy 24:1194-203.
14. Chu CC, Huang CC, Chen RS, Shih TS. 1995. Polyneuropathy induced by carbon disulphide in viscose rayon workers. Occup Environ Med 52:404-407.
15. Corsi G, Maestrelli P, Picotti G, Manzoni S, Negrin P. 1983. Chronic peripheral neuropathy in workers with previous exposure to carbon disulphide. Br J Ind Med 40:209-211.
16. Crofton KM, Padilla S, Tilson HA, Anthony DC, Raymer JH, Mac Phail RC. 1996. The impact of dose rate on the neurotoxicity of acrylamide: The interaction of administered dose, target tissue concentrations, tissue damage, and functional effects. Toxicol Appl Pharmacol 139:163-176.
17. De Grandchamp RL, Lowndes HE. 1990. Early degeneration and sprouting at the rat neuromuscular junction following acrylamide administration. Neuropathol Appl Neurobiol 16:239-254.
18. De Grandchamp RL, Reuhl KR, Lowndes HE. 1990. Synaptic terminal degeneration and remodeling at the rat neuromuscular junction resulting from a single exposure to acrylamide. Toxicol Appl Pharmacol 105:422-433.
19. Ehrich M, Jortner BS. 2002. Organophosphate-induced delayed neuropathy. In: Massaro EJ, ed. Handbook of Neurotoxicology. Vol. 1. Totowa, NJ: Humana Press. p. 17-27.
20. Ehrich M, Jortner BS. 2010. Organophosphate-induced delayed neuropathy. In: Krieger R, ed. Hayes' Handbook of Pesticide Toxicology. Vol. 2. San Diego: Elsevier. p. 1479-1504.
21. El-Fawal HA, Correll L, Gay L, Ehrich M. 1990. Protease activity in brain, nerve, and muscle of hens given neuropathy-inducing organophosphates and a calcium channel blocker. Toxicol Appl Pharmacol 103:133-142.
22. Ergun SS, Ozturk K, Su O, Gursoy EB, Ugurad I, Yuksel G. 2009. Delayed neuropathy due to organophosphate insecticide injection in an attempt to commit suicide. Hand (N Y) 4:84-87.
23. Feldman RG, Niles CA, Kelly-Hayes M, Sax DS, Dixon WJ, Thompson DJ, Landau E. 1979. Peripheral neuropathy in arsenic smelter workers. Neurology 29:939-944.
24. Fix AS, Garman RH. 2000. Practical aspects of neuropathology: a technical guide for working with the nervous system. Toxicol Pathol 28:122-131. Gottfried MR, Graham DG, Morgan M, Casey HW, Bus JS. 1985. The morphology of carbon disulfide neurotoxicity. Neurotoxicology 6:89-96.
25. Gottfried MR, Graham DG, Morgan M, Casey HW, Bus JS. 1985. The morphology of carbon disulfide neurotoxicity. Neurotoxicology 6:89-96.
26. Graham DG, Amarnath V, Valentine WM, Pyle SJ, Anthony DC. 1995. Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit Rev Toxicol 25:91-112.
27. Graham DG, Anthony DC, Boekelheide K, Maschmann NA, Richards RG, Wolfram JW, Shaw BR. 1982. Studies of the molecular pathogenesis of hexane neuropathy. II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking. Toxicol Appl Pharmacol 64:415-422.
28. Grandjean P, Landrigan PJ. 2006. Developmental neurotoxicity of industrial chemicals. Lancet 368:2167-2178.
29. Herskowitz A, Ishii N, Schaumburg H. (1971). N-hexane neuropathy. A syndrome occurring as a result of industrial exposure. NEngl JMed 285:82-85. Holisaz MT, Rayegani SM, Hafezy R, Khedmat H, Motamedi MH. 2007. Screening for peripheral neuropathy in chemical warfare victims. Int J Rehabil Res 30:71-74.
30. Holisaz MT, Rayegani SM, Hafezy R, Khedmat H, Motamedi MH. 2007. Screening for peripheral neuropathy in chemical warfare victims. Int J Rehabil Res 30:71-74.
31. Holzbauer SM, De Vries AS, Sejvar JJ, Lees CH, Adjemian J, McQuiston JH, Medus C, Lexau CA, Harris JR, Recuenco SE, Belay ED, Howell JF, Buss BF, Hornig M, Gibbins JD, Brueck SE, Smith KE, Danila RN, Lipkin WI, Lachance DH, Dyck PJ, Lynfield R. 2010. Epidemiologic investigation of immune-mediated polyradiculoneuropathy among abattoir workers exposed to porcine brain. PLoS One 5:e9782.
32. Horan JM, Kurt TL, Landrigan PJ, Melius JM, Singal M. 1985. Neurologic dysfunction from exposure to 2-t-butylazo-2-hydroxy-5-methylhexane (BHMH): A new occupational neuropathy. Am J Public Health 75:513-517.
33. Jortner BS. 2000. Mechanisms of toxic injury in the peripheral nervous system: neuropathologic considerations. Toxicol Pathol 28:54-69. Jortner BS. 2011. Preparation and analysis of the peripheral nervous system. Toxicol Pathol 39:66-72.
34. Jortner BS. 2011. Preparation and analysis of the peripheral nervous system. Toxicol Pathol 39:66-72.
35. Jortner BS, Shell L, El-Fawal H, Ehrich M. 1989. Myelinated nerve fiber regeneration following organophosphorus ester-induced delayed neuropathy. Neurotoxicology 10:717-726.
36. Kasukurthi R, Brenner MJ, Moore AM, Moradzadeh A, Ray WZ, Santosa KB, Mackinnon SE, Hunter DA. 2009. Transcardial perfusion versus immersion fixation for assessment of peripheral nerve regeneration. J Neurosci Methods 184:303-309.
37. King RHM. 1999. Atlas of Peripheral Nerve Pathology. London: Arnold Publishers.
38. Kjuus H, Goffeng LO, Heier MS, Sjoholm H, Ovrebo S, Skaug V, Paulsson B, Tornqvist M, Brudal S. 2004. Effects on the peripheral nervous system of tunnel workers exposed to acrylamide and N-methylolacrylamide. Scand J Work Environ Health 30:21-29.
39. Krinke GJ, Fitzgerald RE. 1988. The pattern of pyridoxine-induced lesion: Difference between the high and the low toxic level. Toxicology 49:171-178.
40. Krinke GJ, Vidotto N, Weber E. 2000. Teased-fiber technique for peripheral myelinated nerves: methodology and interpretation. Toxicol Pathol 28:113-121.
41. Lachance DH, Lennon VA, Pittock SJ, Tracy JA, Krecke KN, Amrami KK, Poeschla EM, Orenstein R, Scheithauer BW, Sejvar JJ, Holzbauer S, Devries AS, Dyck PJ. 2010. An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: A descriptive study. Lancet Neurol 9:55-66.
42. Lauria G, Lombardi R, Borgna M, Penza P, Bianchi R, Savino C, Canta A, Nicolini G, Marmiroli P, Cavaletti G. 2005. Intraepidermal nerve fiber density in rat foot pad: Neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst 10:202-208.
43. Lauria G, Lombardi R, Camozzi F, Devigili G. 2009. Skin biopsy for the diagnosis of peripheral neuropathy. Histopathology 54:273-285.
44. Lehning EJ, Balaban CD, Ross JF, Reid MA, Lo Pachin RM. 2002. Acrylamide neuropathy: I. Spatiotemporal characteristics of nerve cell damage in rat cerebellum. Neurotoxicology 23:397-414.
45. Lehning EJ, Dyer KS, Jortner BS, Lo Pachin RM. 1995. Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy. Toxicol Appl Pharmacol 135:58-66.
46. Lehning EJ, Persaud A, Dyer KR, Jortner BS, Lo Pachin RM. 1998. Biochemical and morphologic characterization of acrylamide peripheral neuropathy. Toxicol Appl Pharmacol 151:211-221.
47. Lo Pachin RM, Balaban CD, Ross JF. 2003. Acrylamide axonopathy revisited. Toxicol Appl Pharmacol 188:135-153.
48. Lo Pachin RM, Lehning EJ, Opanashuk LA, Jortner BS. 2000. Rate of neurotoxicant exposure determines morphologic manifestations of distal axonopathy. Toxicol Appl Pharmacol 167:75-86.
49. Lotti M, Moretto A. 2005. Organophosphare-induced delayed polyneuropathy. Toxicol Rev 24:37-49.
50. Mallov JS. 1976. MBK meuropathy among spray painters. JAMA 235:1455-1457.
51. Mendell JR, Saida K, Ganansia MF, Jackson DB, Weiss H, Gardier RW, Chrisman C, Allen N, Couri D, O'neill J, Marks B, Hetland L. 1974. Toxic polyneuropathy produced by methyl N-butyl ketone. Science 185:787-789.
52. Miyakawa T, Murayama E, Sumiyoshi S, Deshimaru M, Fujimoto T. 1976. Late changes in human sural nerves in Minamata disease and in nerves of rats with experimental organic mercury poisoning. Acta Neuropathol 35:131-138.
53. Morgan JP, Penovich P. 1978. Jamaica ginger paralysis. Forty-seven-year follow-up. Arch Neurol 35:530-532.
54. Moser VC, Phillips PM, Morgan DL, Sills RC. 1998. Carbon disulfide neurotoxicity in rats: VII. Behavioral evaluations using a functional observational battery. Neurotoxicology 19:147-157.
55. Myers JE, Macun I. 1991. Acrylamide neuropathy in a South African factory: An epidemiologic investigation. Am J Ind Med 19:487-493.
56. Neghab M, Soleimani E, Khamoushian K. 2012. Electrophysiological studies of shoemakers exposed to sub-TLV levels of n-hexane. J Occup Health 54:376-382.
57. Ninomiya T, Imamura K, Kuwahata M, Kindaichi M, Susa M, Ekino S. 2005. Reappraisal of somatosensory disorders in methylmercury poisoning. Neurotoxicol Teratol 27:643-653.
58. Olsson Y. 1984. Vascular permeability in the peripheral nervous system. In Dyck PJ, Thomas PK, Lampert EH, Bunge R, eds. Peripheral Neuropathy. Philadelphia: WB Saunders. p 579-597.
59. Osuntokun BO, Aladetoyinbo A, Adeuja AO. 1970. Free-cyanide levels in tropical ataxic neuropathy. Lancet 2:372-373.
60. Pope C, Ci Lorenzo K, Ehrich M. 1995. Possible involvement of a neurotrophic factor during the early stages of organophosphate-induced delayed neurotoxicity. Toxicol Lett 75:111-117.
61. Prineas J. 1969. The pathogenesis of dying-back polyneuropathies. II. An ultrastructural study of experimental acrylamide intoxication in the cat. J Neuropathol Exp Neurol 28:598-621.
62. Prockop LD, Alt M, Tison J. 1974. "Huffer's" neuropathy. JAMA 229:1083-1084.
63. Puri V, Chaudhry N, Tatke M. 2007. N-hexane neuropathy in screen printers. Electromyogr Clin Neurophysiol 47:145-152.
64. Richardson RJ. 1995. Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: A critical review of the literature. J Toxicol Environ Health 44:135-165.
65. Rizzuto N, Terzian H, Galiazzo-Rizzuto S. 1977. Toxic polyneuropathies in Italy due to leather cement poisoning in shoe industries. A light- and electron-microscopic study. J Neurol Sci 31:343-354.
66. Schaumburg HH. 2000. Pyridoxine. In Spencer PS, Schaumburg HH, Ludolph AC, eds. Experimental and Clinical Neurotoxicology. New York: Oxford University Press.
67. Schloss JM, Colosimo M, Airey C, Masci PP, Linnane AW, Vitetta L. 2013. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): A systematic review. Clin Nutr 32:888-893.
68. Scott K, Zeris S, Kothari MJ. 2008. Elevated B6 levels and peripheral neuropathies. Electromyogr Clin Neurophysiol 48:219-223.
69. Senanayake N, Jeyaratnam J. 1981. Toxic polyneuropathy due to gingili oil contaminated with tri-cresyl phosphate affecting adolescent girls in Sri Lanka. Lancet 1:88-89.
70. Shobha N, Taly AB, Sinha S, Venkatesh T. 2009. Radial neuropathy due to occupational lead exposure: Phenotypic and electrophysiological characteristics of five patients. Ann Indian Acad Neurol 12:111-115.
71. Sills RC, Harry GJ, Morgan DL, Valentine WM, Graham DG. 1998. Carbon disulfide neurotoxicity in rats: V. Morphology of axonal swelling in the muscular branch of the posterior tibial nerve and spinal cord. Neurotoxicology 19:117-127.
72. Smith HV, Spalding JM. 1959. Outbreak of paralysis in Morocco due to ortho-cresyl phosphate poisoning. Lancet 2:1019-1021.
73. Spencer PS, Schaumburg HH. 1974. A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms. Can J Neurol Sci 1:152-169.
74. Spencer PS, Schaumburg HH. 1977. Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration. J Neuropathol Exp Neurol 36:276-299.
75. Spencer PS, Schaumburg HH. 1980. Classification of neurotoxic disease: A morphological approach. In Spencer PS, Schaumberg HH, eds. Experimental and Clinical Neurotoxicology Baltimore: Williams and Wilkins. p 92-99.
76. Spencer PS, Schaumburg HH, eds. 2000. Experimental and Clinical Neurotoxicology. New York: Oxford University Press.
77. Susser M, Stein Z. 1957. An outbreak of tri-ortho-cresyl phosphate (T.O.C.P.) poisoning in Durban. Br J Ind Med 14:111-120.
78. Tareke E, Rydberg P, Karlsson P, Eriksson S, TornqvistM. 2000. Acrylamide: A cooking carcinogen?. Chem Res Toxicol 13:517-522.
79. Towfighi J, Gonatas NK, Pleasure D, Cooper HS, Mc Cree L. 1976. Glue sniffer's neuropathy. Neurology 26:238-243.
80. US Environmental Protection Agency, Office of Pollution, Prevention, and Toxics. 2010 Chemical testing and data evaluation. Available online (www.epa.gov/opptintr/chemtest/), accessed on July 10, 2013.
81. Valentine WM, Amarnath V, Graham DG, Morgan DL, Sills RC. 1997. CS2-mediated cross-linking of erythrocyte spectrin and neurofilament protein: Dose response and temporal relationship to the formation of axonal swellings. Toxicol Appl Pharmacol 142:95-105.
82. Wadia NH. 1984. SMON as seen from Bombay. Acta Neurol Scand Suppl 100:159-164.
83. Weimer LH, Sachdev N. 2009. Update on medication-induced peripheral neuropathy. Curr Neurol Neurosci Rep 9:69-75.
84. White RF, Feldman RG, Eviator II, Jabre JF, Niles CA. 1997. Hazardous waste and neurobehavioral effects: A developmental perspective. Environ Res 73:113-124.
85. Windebank AJ, Low PA, Blexrud MD, Schmelzer JD, Schaumburg HH. 1985. Pyridoxine neuropathy in rats: Specific degeneration of sensory axons. Neurology 35:1617-1622.
86. Woolf AD. 1995. Ginger Jake and the blues: A tragic song of poisoning. Vet Hum Toxicol 37:252-254.
87. Xu Y, Sladky JT, Brown MJ. 1989. Dose-dependent expression of neuronopathy after experimental pyridoxine intoxication. Neurology 39:1077-1083.
88. Yokoyama K, Araki S, Murata K, Nishikitani M, Okumura T, Ishimatsu S, Takasu N. 1998. Chronic neurobehavioral and central and autonomic nervous system effects of Tokyo subway sarin poisoning. J Physiol Paris 92:317-323.
89. Zheng H, Xiao WH, Bennett GJ. 2012. Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy. Exp Neurol 238:225-234.